Aug 4, 2022, 2:34 PM
Dr. Sanchez provides a final update on his novel tongue EIM assessment device.
Nov 22, 2021, 12:27 PM
Dr. Sanchez provides an update on the initial phase of his clinical trial
Nov 13, 2021, 12:14 PM
Dr. Bloch provides a final report on progress.
Oct 14, 2020, 1:27 PM
Dr. Bloch provides an update on progress investigating a potential biomarker for FSHD.
Aug 1, 2019, 5:52 PM
Sujatha Jagannathan provides a brief final summary of work on her research.
Aug 1, 2019, 12:24 PM
Yi-Wen Chen provides a final summary of her research activities.
Dec 18, 2018, 8:36 PM
Yi-Wen Chen provides a summary of the first six months of research activities.
May 30, 2018, 10:18 AM
Exciting new research being funded both by your investments and through our co-funding partners.
Publication: Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures
May 25, 2018, 9:34 AM
Identification of several types of small noncoding RNAs including known microRNAs that are differentially expressed in FSHD2 muscle cells compared to control.
Dec 31, 2017, 8:55 PM
Initial progress update provided by Premi Haynes PhD.
Dec 16, 2017, 8:50 PM
Follow-on publication for previously funded grant.
Feb 9, 2017, 2:00 PM
The University of Washington is seeking individuals to participate in a research study aimed at identifying biomarkers of FSHD.
Oct 26, 2016, 9:55 AM
A proposal to study the histopathological features of muscle in a large biobank from FSHD patients and their first degree family members.
Jun 17, 2016, 5:36 PM
Sheila had the pleasure of meeting with Daniel G. Miller, Geneticist at Seattle Children’s Hospital, and Associate Professor at the University of Washington. Dr. Miller and colleagues from the University of Rochester, the University of Washington, and Seattle Children’s Hospital recently published a cross sectional study of two independent groups of people with FSHD, and identified serum biomarkers. The landmark study was published in the journal Neuromuscular Disorders.
May 23, 2016, 4:44 PM
Report of FSHD Summit held in Portland, Oregon, February 29 to March 1 of 2016.
May 14, 2016, 4:11 PM
What should we use to track the benefits of a treatment in clinical trials for FSHD?
Mar 28, 2015, 3:08 PM
At the MDA scientific conference held in Washington D.C. in March, Dr. Daniel Miller presented his unpublished data on biomarkers in blood (serum) of people with FSHD
Mar 17, 2015, 2:58 PM
FSHD was a hot topic at the MDA scientific conference in Washington D.C.
Feb 3, 2015, 9:07 AM
Progress update from Drs. Miller and Tawil.
Progress Update: Identification of small RNAs generated from the D4Z4 array by deep high-throughput sequencing
Aug 31, 2014, 2:57 PM
Drs. Filippova and Miller present their final results from the study.
Jun 7, 2013, 5:25 PM
Magnetic resonance imaging shows short tau-inversion recovery (STIR) brightness in autosomal dominant FSHD1 suggestive of active inflammation/injury.
Nov 28, 2011, 9:36 AM
Degeneration of muscles in FHSD is associated with fatty replacement on magnetic resonance imaging.